Molecular mechanisms underlying chemical liver injury
- PMID: 22306029
- PMCID: PMC3704158
- DOI: 10.1017/S1462399411002110
Molecular mechanisms underlying chemical liver injury
Abstract
The liver is necessary for survival. Its strategic localisation, blood flow and prominent role in the metabolism of xenobiotics render this organ particularly susceptible to injury by chemicals to which we are ubiquitously exposed. The pathogenesis of most chemical-induced liver injuries is initiated by the metabolic conversion of chemicals into reactive intermediate species, such as electrophilic compounds or free radicals, which can potentially alter the structure and function of cellular macromolecules. Many reactive intermediate species can produce oxidative stress, which can be equally detrimental to the cell. When protective defences are overwhelmed by excess toxicant insult, the effects of reactive intermediate species lead to deregulation of cell signalling pathways and dysfunction of biomolecules, leading to failure of target organelles and eventual cell death. A myriad of genetic factors determine the susceptibility of specific individuals to chemical-induced liver injury. Environmental factors, lifestyle choices and pre-existing pathological conditions also have roles in the pathogenesis of chemical liver injury. Research aimed at elucidating the molecular mechanism of the pathogenesis of chemical-induced liver diseases is fundamental for preventing or devising new modalities of treatment for liver injury by chemicals.
Figures



Similar articles
-
[Toxic liver injuries--a current view on pathogenesis. Part II].Med Pr. 2011;62(2):203-10. Med Pr. 2011. PMID: 21698879 Review. Polish.
-
Animal models of hepatotoxicity.Inflamm Res. 2016 Jan;65(1):13-24. doi: 10.1007/s00011-015-0883-0. Epub 2015 Oct 1. Inflamm Res. 2016. PMID: 26427493 Review.
-
[Toxic liver injuries--a current view on pathogenesis. Part I].Med Pr. 2011;62(1):47-55. Med Pr. 2011. PMID: 21748883 Review. Polish.
-
Melatonin's role in preventing toxin-related and sepsis-mediated hepatic damage: A review.Pharmacol Res. 2016 Mar;105:108-20. doi: 10.1016/j.phrs.2016.01.018. Epub 2016 Jan 22. Pharmacol Res. 2016. PMID: 26808084 Review.
-
Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes--conclusions from the 3rd International ESTP Expert Workshop.Toxicol Pathol. 2012 Oct;40(7):971-94. doi: 10.1177/0192623312448935. Epub 2012 Jun 21. Toxicol Pathol. 2012. PMID: 22723046 Review.
Cited by
-
Gold Nanoparticles Perturb Drug-Metabolizing Enzymes and Antioxidants in the Livers of Male Rats: Potential Impact on Drug Interactions.Int J Nanomedicine. 2020 Jul 14;15:5005-5016. doi: 10.2147/IJN.S248194. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32764932 Free PMC article.
-
Hepatoprotection by Traditional Essence of Ginseng against Carbon Tetrachloride-Induced Liver Damage.Nutrients. 2020 Oct 21;12(10):3214. doi: 10.3390/nu12103214. Nutrients. 2020. PMID: 33096694 Free PMC article.
-
Water-soluble pristine C60 fullerene attenuates acetaminophen-induced liver injury.Bioimpacts. 2019;9(4):227-237. doi: 10.15171/bi.2019.28. Epub 2019 May 22. Bioimpacts. 2019. PMID: 31799159 Free PMC article.
-
Amelioration of aflatoxin acute hepatitis rat model by bone marrow mesenchymal stem cells and their hepatogenic differentiation.Vet World. 2022 May;15(5):1347-1364. doi: 10.14202/vetworld.2022.1347-1364. Epub 2022 May 27. Vet World. 2022. PMID: 35765490 Free PMC article.
-
miR-15a-3p Protects Against Isoniazid-Induced Liver Injury via Suppressing N-Acetyltransferase 2 Expression.Front Mol Biosci. 2021 Nov 23;8:752072. doi: 10.3389/fmolb.2021.752072. eCollection 2021. Front Mol Biosci. 2021. PMID: 34888351 Free PMC article.
References
-
- Nemeth E, Baird AW, O’Farrelly C. Microanatomy of the liver immune system. Seminars in Immunopathology. 2009;31:333–343. - PubMed
-
- Dienes HP, Drebber U. Pathology of immune-mediated liver injury. Digestive Diseases. 2010;28:57–62. - PubMed
-
- Misdraji J. Embryology, anatomy, histology, and developmental anomalies of the liver. In: Sleisenger MH, Feldman M, et al., editors. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 9. Saunders/Elsevier; Philadelphia, PA: 2010. pp. 1201–1206.
-
- Carithers RL, Jr, Mcclain CJ. Alcoholic liver disease. In: Sleisenger MH, Feldman M, et al., editors. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 9. Saunders/Elsevier; Philadelphia, PA: 2010. pp. 1383–1400.
-
- Jungermann K, Kietzmann T. Zonation of parenchymal and nonparenchymal metabolism in liver. Annual Review of Nutrition. 1996;16:179–203. - PubMed
Further reading, resources and contacts
-
- Gregus Z. Mechanism of toxicity. In: Casarett LJ, Doull J, et al., editors. Casarett and Doull’s Toxicology: The Basic Science of Poisons. 7. McGraw-Hill; New York: 2008. pp. 45–106. This book chapter provides the most comprehensive and detailed information on the molecular and cellular mechanism of toxicity by xenobiotics.
-
- Kaplowitz N. Biochemical and cellular mechanisms of toxic liver injury. Seminars in Liver Disease. 2002;22:137–144. This review focuses on the mechanisms of different forms of cell death. - PubMed
-
- Abboud G, Kaplowitz N. Drug-induced liver injury. Drug Safety. 2007;30:277–294. This review provides practical information on the diagnosis and management of patients with suspected drug-related liver disease. Pathogenesis is also discussed briefly. - PubMed
-
- Testa B, Kramer SD. The biochemistry of drug metabolism – an introduction: parts 2–5. Redox, hydrolysis, conjugation reactions and their enzymes, metabolism and bioactivity. Chemistry and Biodiversity. 2007–2009;4456:257–405. 2031–2122, 2171–2336, 591–684. - PubMed
-
- Parkinson A, Ogilvie BW. Biotransformation of xenobiotics. In: Casarett LJ, Doull J, et al., editors. Casarett and Doull’s Toxicology: The Basic Science of Poisons. 7. McGraw-Hill; New York: 2008. pp. 161–304. The reviews by Test and Kramer and the book chapter by Parkinson and Ogilvie demonstrate comprehensive and detailed information on detoxification and bio-activation of xenobiotics.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical